BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang B, Wang D, Huang G, Zhang C, Xu DH, Zhou W. XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis. Int J Colorectal Dis 2010;25:313-21. [PMID: 20033188 DOI: 10.1007/s00384-009-0866-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Liu M, Qiu Z, Yang Q, Diwakar M. Association between ERCC1 Gene Polymorphism (rs11615) and Colorectal Cancer Susceptibility: A Meta-Analysis of Medical Image Fusion and Safety Applications. Computational and Mathematical Methods in Medicine 2022;2022:1-11. [DOI: 10.1155/2022/9988513] [Reference Citation Analysis]
2 Banday MZ, Sameer AS, Nissar S. Colorectal Cancer and Genetic Polymorphism in Key Regulatory Low Penetrance Genes. Genetic Polymorphism and cancer susceptibility 2021. [DOI: 10.1007/978-981-33-6699-2_5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Mehrzad J, Dayyani M, Erfanian-Khorasani M. The independent and combined effects of selected risk factors and Arg399Gln XRCC1 polymorphism in the risk of colorectal cancer among an Iranian population. Med J Islam Repub Iran 2020;34:75. [PMID: 33306066 DOI: 10.34171/mjiri.34.75] [Reference Citation Analysis]
4 Asgerov E, Şenol Ö, Güler A, Berdeli A. Distribution of nucleotide variants in the DNA sequence of ERCC1 and XRCC1 genes and the effect of phenotype in patients with gastric cancer. Turk J Gastroenterol 2019;30:517-23. [PMID: 31144657 DOI: 10.5152/tjg.2019.18100] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Singh N, Kazim SN, Sultana R, Tiwari D, Borkotoky R, Kakati S, Nath Das N, Kumar Saikia A, Bose S. Oxidative stress and deregulations in base excision repair pathway as contributors to gallbladder anomalies and carcinoma - a study involving North-East Indian population. Free Radic Res 2019;53:473-85. [PMID: 31117842 DOI: 10.1080/10715762.2019.1606423] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Lau TP, Lian LH, Cheah PL, Looi LM, Roslani AC, Goh KL, Lee PC, Chua KH. Lack of correlation between X-ray repair cross-complementing group 1 gene polymorphisms and the susceptibility to colorectal cancer in a Malaysian cohort. Eur J Cancer Prev 2017;26:506-10. [PMID: 28059856 DOI: 10.1097/CEJ.0000000000000336] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
7 Adampourezare M, Hosseinpourefeizi M, Pouladi N, Hosseinpourefeizi E, Azarfam P. Association of Arg194Trp and Arg399Gln Polymorphisms of XRCC1 Gene and Risk of Differentiated Thyroid Carcinoma in Iranian-Azeri Patients. Int J Cancer Manag 2017;10. [DOI: 10.5812/ijcm.5790] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Yan J, Wang X, Tao H, Deng Z, Yang W, Lin F. Meta-Analysis of the Relationship between XRCC1-Arg399Gln and Arg280His Polymorphisms and the Risk of Prostate Cancer. Sci Rep 2015;5:9905. [PMID: 25927275 DOI: 10.1038/srep09905] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
9 Qin CJ, Xu KW, Chen ZH, Zhai ET, He YL, Song XM. XRCC1 R399Q polymorphism and colorectal cancer risk in the Chinese Han population: a meta-analysis. Tumour Biol 2015;36:461-6. [PMID: 25582318 DOI: 10.1007/s13277-015-3054-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
10 Feng YZ, Liu YL, He XF, Wei W, Shen XL, Xie DL. Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies. Tumour Biol 2014;35:10677-97. [PMID: 25064613 DOI: 10.1007/s13277-014-2326-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
11 Zhang X, Jiang LP, Yin Y, Wang YD. XRCC1 and XPD genetic polymorphisms and clinical outcomes of gastric cancer patients treated with oxaliplatin-based chemotherapy: a meta-analysis. Tumour Biol 2014;35:5637-45. [PMID: 24590266 DOI: 10.1007/s13277-014-1746-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
12 Mao D, Zhang Y, Lu H, Fu X. Association between X-ray repair cross-complementing group 1 Arg194Trp polymorphism and colorectal cancer risk. Tumor Biol 2013;34:2529-38. [DOI: 10.1007/s13277-013-0760-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
13 Tian Z, Li Y, Liu J. XRCC1 Arg399Gln polymorphism contributes to increased risk of colorectal cancer in Chinese population. Mol Biol Rep 2013;40:4147-51. [DOI: 10.1007/s11033-012-2463-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
14 Zhuo W, Zhang L, Cai L, Zhu B, Chen Z. XRCC1 Arg399Gln polymorphism and bladder cancer risk: updated meta-analyses based on 5767 cases and 6919 controls. Exp Biol Med (Maywood) 2013;238:66-76. [PMID: 23479765 DOI: 10.1258/ebm.2012.012209] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
15 Gulnaz A, Sayyed AH, Amin F, Khan Au, Aslam MA, Shaikh RS, Ali M. Association of XRCC1, XRCC3, and XPD genetic polymorphism with an increased risk of hepatocellular carcinoma because of the hepatitis B and C virus. Eur J Gastroenterol Hepatol 2013;25:166-79. [PMID: 23044807 DOI: 10.1097/MEG.0b013e328359a775] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
16 Jiang L, Fang X, Bao Y, Zhou JY, Shen XY, Ding MH, Chen Y, Hu GH, Lu YC. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies. PLoS One 2013;8:e55597. [PMID: 23383237 DOI: 10.1371/journal.pone.0055597] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
17 Liu L, Miao L, Ji G, Qiang F, Liu Z, Fan Z. Association between XRCC1 and XRCC3 polymorphisms and colorectal cancer risk: a meta-analysis of 23 case-control studies. Mol Biol Rep 2013;40:3943-52. [PMID: 23271134 DOI: 10.1007/s11033-012-2471-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
18 Zhang K, Zhou B, Wang Y, Rao L, Zhang L. The XRCC1 Arg280His polymorphism contributes to cancer susceptibility: an update by meta-analysis of 53 individual studies. Gene 2012;510:93-101. [DOI: 10.1016/j.gene.2012.08.039] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
19 Zeng FR, Ling Y, Yang J, Tian XC, Yang X, Luo RC. X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer: a meta-analysis. Tumour Biol. 2013;34:555-563. [PMID: 23188703 DOI: 10.1007/s13277-012-0581-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
20 Wei X, Chen D, Lv T. A functional polymorphism in XRCC1 is associated with glioma risk: evidence from a meta-analysis. Mol Biol Rep 2013;40:567-72. [PMID: 23096083 DOI: 10.1007/s11033-012-2093-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
21 Li J, Li Z, Feng L, Guo W, Zhang S. Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis. Tumour Biol 2013;34:261-9. [PMID: 23055199 DOI: 10.1007/s13277-012-0546-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
22 Karahalil B, Bohr VA, Wilson DM. Impact of DNA polymorphisms in key DNA base excision repair proteins on cancer risk. Hum Exp Toxicol. 2012;31:981-1005. [PMID: 23023028 DOI: 10.1177/0960327112444476] [Cited by in Crossref: 81] [Cited by in F6Publishing: 89] [Article Influence: 7.4] [Reference Citation Analysis]
23 Theodoratou E, Montazeri Z, Hawken S, Allum GC, Gong J, Tait V, Kirac I, Tazari M, Farrington SM, Demarsh A, Zgaga L, Landry D, Benson HE, Read SH, Rudan I, Tenesa A, Dunlop MG, Campbell H, Little J. Systematic Meta-Analyses and Field Synopsis of Genetic Association Studies in Colorectal Cancer. JNCI Journal of the National Cancer Institute 2012;104:1433-57. [DOI: 10.1093/jnci/djs369] [Cited by in Crossref: 79] [Cited by in F6Publishing: 85] [Article Influence: 7.2] [Reference Citation Analysis]
24 Simonelli V, Mazzei F, D'Errico M, Dogliotti E. Reprint of: gene susceptibility to oxidative damage: from single nucleotide polymorphisms to function. Mutat Res 2012;736:104-16. [PMID: 22732424 DOI: 10.1016/j.mrfmmm.2012.06.003] [Reference Citation Analysis]
25 Ricceri F, Matullo G, Vineis P. Is there evidence of involvement of DNA repair polymorphisms in human cancer? Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2012;736:117-21. [DOI: 10.1016/j.mrfmmm.2011.07.013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
26 Wang R, Hu X, Zhou Y, Feng Q, Su L, Long J, Wei B. XRCC1 Arg399Gln and Arg194Trp polymorphisms in childhood acute lymphoblastic leukemia risk: a meta-analysis. Leukemia & Lymphoma 2012;54:153-9. [DOI: 10.3109/10428194.2012.704031] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
27 Tomlinson IP, Houlston RS, Montgomery GW, Sieber OM, Dunlop MG. Investigation of the effects of DNA repair gene polymorphisms on the risk of colorectal cancer. Mutagenesis. 2012;27:219-223. [PMID: 22294770 DOI: 10.1093/mutage/ger070] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
28 Simonelli V, Mazzei F, D’errico M, Dogliotti E. Gene susceptibility to oxidative damage: From single nucleotide polymorphisms to function. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2012;731:1-13. [DOI: 10.1016/j.mrfmmm.2011.10.012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
29 Xuan C, Zhang BB, Yang T, Deng KF, Li M, Tian RJ. Association between OCTN1/2 gene polymorphisms (1672C-T, 207G-C) and susceptibility of Crohn's disease: a meta-analysis. Int J Colorectal Dis 2012;27:11-9. [PMID: 21706137 DOI: 10.1007/s00384-011-1265-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
30 Gsur A, Bernhart K, Baierl A, Feik E, Führlinger G, Hofer P, Leeb G, Mach K, Micksche M. No association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk. Cancer Epidemiol. 2011;35:e38-e41. [PMID: 21612998 DOI: 10.1016/j.canep.2011.03.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
31 Chen B, Zhou Y, Yang P, Wu XT. Polymorphisms of XRCC1 and gastric cancer susceptibility: a meta-analysis. Mol Biol Rep. 2012;39:1305-1313. [PMID: 21604176 DOI: 10.1007/s11033-011-0863-6] [Cited by in Crossref: 37] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
32 Gil J, Ramsey D, Stembalska A, Karpinski P, Pesz KA, Laczmanska I, Leszczynski P, Grzebieniak Z, Sasiadek MM. The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual’s susceptibility to sporadic colorectal cancer. Mol Biol Rep. 2012;39:527-534. [PMID: 21559836 DOI: 10.1007/s11033-0110767-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Gil J, Ramsey D, Stembalska A, Karpinski P, Pesz KA, Laczmanska I, Leszczynski P, Grzebieniak Z, Sasiadek MM. The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual's susceptibility to sporadic colorectal cancer. Mol Biol Rep 2012;39:527-34. [PMID: 21559836 DOI: 10.1007/s11033-011-0767-5] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 4.2] [Reference Citation Analysis]
34 Migliore L, Migheli F, Spisni R, Coppedè F. Genetics, cytogenetics, and epigenetics of colorectal cancer. J Biomed Biotechnol 2011;2011:792362. [PMID: 21490705 DOI: 10.1155/2011/792362] [Cited by in Crossref: 147] [Cited by in F6Publishing: 174] [Article Influence: 12.3] [Reference Citation Analysis]
35 Tahara T, Shibata T, Nakamura M, Okubo M, Yamashita H, Yoshioka D, Yonemura J, Hirata I, Arisawa T. Association between polymorphisms in the XRCC1 and GST genes, and CpG island methylation status in colonic mucosa in ulcerative colitis. Virchows Arch 2011;458:205-11. [PMID: 21234761 DOI: 10.1007/s00428-010-1038-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
36 Wang P, Tang JT, Peng YS, Chen XY, Zhang YJ, Fang JY. XRCC1 downregulated through promoter hypermethylation is involved in human gastric carcinogenesis. J Dig Dis 2010;11:343-51. [PMID: 21091896 DOI: 10.1111/j.1751-2980.2010.00459.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]